Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 78 000 KRW 1.3% Market Closed
Market Cap: 1.1T KRW

Intrinsic Value

The intrinsic value of one Chong Kun Dang Pharmaceutical Corp stock under the Base Case scenario is 80 809.93 KRW. Compared to the current market price of 78 000 KRW, Chong Kun Dang Pharmaceutical Corp is Undervalued by 3%.

Intrinsic Value
80 809.93 KRW
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Chong Kun Dang Pharmaceutical Corp

Chong Kun Dang Pharmaceutical Corp
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Chong Kun Dang Pharmaceutical Corp cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Chong Kun Dang Pharmaceutical Corp
KRX:185750
KR
Pharmaceuticals
Market Cap
1T KRW
IPO
Dec 6, 2013
KR
Pharmaceuticals
Market Cap
1T KRW
IPO
Dec 6, 2013
Price
â‚©false
EPS
â‚©false
Chong Kun Dang Pharmaceutical Corp
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Chong Kun Dang Pharmaceutical Corp?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Chong Kun Dang Pharmaceutical Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chong Kun Dang Pharmaceutical Corp

Current Assets 962.2B
Cash & Short-Term Investments 301.6B
Receivables 298.5B
Other Current Assets 362.1B
Non-Current Assets 496.6B
Long-Term Investments 67.9B
PP&E 320.8B
Intangibles 75.6B
Other Non-Current Assets 32.3B
Efficiency

Free Cash Flow Analysis
Chong Kun Dang Pharmaceutical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Chong Kun Dang Pharmaceutical Corp

Revenue
1.6T KRW
Cost of Revenue
-1.1T KRW
Gross Profit
532.6B KRW
Operating Expenses
-433.1B KRW
Operating Income
99.5B KRW
Other Expenses
9.6B KRW
Net Income
109.1B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chong Kun Dang Pharmaceutical Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Negative Free Cash Flow
56/100
Profitability
Score

Chong Kun Dang Pharmaceutical Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chong Kun Dang Pharmaceutical Corp's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
72/100
Solvency
Score

Chong Kun Dang Pharmaceutical Corp's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chong Kun Dang Pharmaceutical Corp

Wall Street analysts forecast Chong Kun Dang Pharmaceutical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chong Kun Dang Pharmaceutical Corp is 123 998.44 KRW with a low forecast of 96 190.49 KRW and a high forecast of 149 100 KRW.

Lowest
Price Target
96 190.49 KRW
23% Upside
Average
Price Target
123 998.44 KRW
59% Upside
Highest
Price Target
149 100 KRW
91% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Chong Kun Dang Pharmaceutical Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Chong Kun Dang Pharmaceutical Corp stock?

The intrinsic value of one Chong Kun Dang Pharmaceutical Corp stock under the Base Case scenario is 80 809.93 KRW.

Is Chong Kun Dang Pharmaceutical Corp stock undervalued or overvalued?

Compared to the current market price of 78 000 KRW, Chong Kun Dang Pharmaceutical Corp is Undervalued by 3%.

Back to Top